A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors

NCT05162469 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Cancer

Interventions

DRUG: SHR-1909 injection

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.